Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

  1. Lekuona, I.
  2. Anguita, M.
  3. Zamorano, J.L.
  4. Rodríguez, J.M.
  5. Barja de Soroa, P.
  6. Pérez-Alcántara, F.
Revue:
Revista Espanola de Cardiologia

ISSN: 1579-2242,  0300-8932

Année de publication: 2019

Volumen: 72

Número: 5

Pages: 398-406

Type: Article

DOI: 10.1016/J.RECESP.2018.03.017 GOOGLE SCHOLAR
La source de données: Scopus